Cyclophosphamide Overview Categories 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics2.4 Disease modifying antirheumatic drugs 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Cyclophosphamide Manufacturers of Cyclophosphamide Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Cyclophosphamide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 2 to 6 mg/kg4 (4)As recommended.IVper week.2 to 6 mg/ kg4 (4)As recommended.POIn div.doses per week. Paedriatic Dosage (20kg) 1250 to 2330 mg/sq.meter1800 (1790)As recommended.Intra VenousPer Month.730 mg/sq.meter1300 (1338)As recommended.OralOn Days 1-5 every month Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Cyclophosphamide is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Cyclophosphamide Back to top Manufacturers of Cyclophosphamide in Pakistan Al-Habib GHANI BROTHERS Pharmedic S.Ejazuddin Back to top Previous Drug Generic - Next Drug Generic